Minerva Neurosciences, Inc - Common Stock — Cash Flow (NASDAQ:NERV) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -33.82 M-24.6 M-24.65 M-14.78 M-19.55 M-13.51 M -26.17 M Cash from investing activities 24.53 M24.53 M-16.33 K-16.33 K00 -50.13 M Cash from financing activities 13.24 M60 M-519.6 M19.6 M74.45 M 85.7 M Free cash flow -33.82 M-24.6 M-24.65 M-14.78 M-19.55 M-13.51 M -26.17 M

News

All You Need to Know About Minerva Neurosciences (NERV) Rating Upgrade to Buy

Minerva Neurosciences (NERV) Loses 37.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

H.C. Wainwright raises Minerva Neurosciences price target on trial design

Minerva Neurosciences, Inc. (NERV) Discusses Roluperidone as a Potential First Treatment for Negative Symptoms of Schizophrenia Transcript

Minerva Neurosciences appoints schizophrenia expert to board of directors

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.47%

Minerva Stock Rises After Securing $200M for Schizophrenia Drug Trial - Minerva Neurosciences (NASDAQ:NERV)

Minerva Neurosciences stock soars after securing $200 million financing

US Stocks Mixed; Coca-Cola Posts Upbeat Earnings - American Rebel Holdings (NASDAQ:AREB), Beyond Meat (NASDAQ:BYND)